Dark

Check out our Dark Pool Levels

FEMY
Femasys Inc. Common Stock
stock NASDAQ

At Close

Jul 21, 2026 3:59:42 PM EDT

3.93USD+20.183%(+0.66)226,093

0.00Bid 0.00Ask 0.00Spread

Pre-market

0.00USD-100.000%(-3.27)0

After-hours

Jul 21, 2026 4:47:30 PM EDT

3.88USD-1.272%(-0.05)2,839

OverviewHistoricalExchangesShortsNews

Jan 20, 2022

08:00AM EST Femasys Inc. Announces the Appointment of Wendy Perrow, GlobeNewswire Inc

Dec 23, 2021

08:05AM EST Femasys Inc. to Participate in Upcoming January Investor Conferences GlobeNewswire Inc

Nov 10, 2021

05:42PM EST Femasys Q3 EPS $(0.19) Up From $(1.64) YoY, Sales $269.58M Up From $313.21K YoY Benzinga

Sep 23, 2021

05:47PM EDT Femasys Inc. to Present at The MedTech Conference GlobeNewswire Inc

Sep 20, 2021

04:08PM EDT Femasys To Join Russell Microcap Index, Effective Date Not Given Benzinga

04:05PM EDT Femasys Inc. To Join the Russell Microcap Index GlobeNewswire Inc

Sep 1, 2021

04:07PM EDT Femasys Names Edward Evantash As Chief Medical Officer Benzinga

04:05PM EDT -- Industry veteran with over than two decades of experience in medical affairs to lead clinical and medical affairs at Femasys -- GlobeNewswire Inc

Aug 11, 2021

04:35PM EDT Femasys Q2 EPS $(0.52) Down From $1.55 YoY Benzinga

04:05PM EDT Completed initial public offering (IPO) raising net proceeds of $31.6 million GlobeNewswire Inc

Jul 20, 2021

08:33AM EDT Femasys Inc. Announces First Patient Treated In Pivotal Trial For FemaSeed Benzinga

08:32AM EDT Femasys Inc. Announces First Patient Treated in Pivotal Trial for GlobeNewswire Inc

Jul 19, 2021

10:41AM EDT 'These 3 Stocks May Be Reaching a Bottom; Analysts Say 'Buy'' -TipRanks, Mentions UpHealth, Femasys, Codex DNA Benzinga

Jul 13, 2021

11:42AM EDT JonesTrading Initiates Coverage On Femasys with Buy Rating, Announces Price Target of $18 Benzinga

10:19AM EDT UPDATE: Chardan On Femasys Buy Initiation: Firm Sees Potential Of Next Generation Products Addressing Women's Reproductive Health To Achieve Significant Market Penetration Given Two Lead Product Candidates FemBloc & FemaSeed Benzinga

10:13AM EDT Benzinga's Top Ratings Upgrades, Downgrades For July 13, 2021 Benzinga

08:06AM EDT Chardan Capital Initiates Coverage On Femasys with Buy Rating, Announces Price Target of $25 Benzinga

Jun 21, 2021

08:50AM EDT Chardan Acts as Lead Left Bookrunner in Femasys' $34.45 Million IPO PR Newswire

Jun 18, 2021

12:14PM EDT Femasys Shares Open For Trade At $13.08; IPO Priced At $13/Share Benzinga

09:23AM EDT Femasys Shares Will Open For Quote At 11:50 a.m. EDT, Expected To Open For Trade After 12 p.m. EDT; IPO Priced At $13/Share Benzinga

Jun 17, 2021

09:04PM EDT Femasys Prices IPO Of 2.65 Mln Shares At $13.00/shr RTTNews

Share